Company intelligence / Profile preview

ProteoMass Australia

Brisbane, Queensland, Australia

Ownership: Private
Development stage: Other

Overview

ProteoMass is an Australian specialist contract research organization (CRO) that provides high-end mass spectrometry and proteomics services to the life sciences sector. Based in Brisbane, the company offers a range of analytical solutions including protein identification, quantitative proteomics, and characterization of post-translational modifications. Their expertise supports drug discovery, clinical biomarker validation, and the development of biotherapeutics. ProteoMass serves a diverse clientele across academia, biotechnology, and the pharmaceutical industry, utilizing advanced instrumentation to solve complex analytical challenges.

Modalities: ProteinsPeptidesSmall molecule
Industry: Contract Research Organization

Partnerships

University of Queensland

Beyond the preview

Go deeper on ProteoMass Australia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProteoMass Australia.

Explore the full profile